Document Detail

Analyses of differential sensitivities of synchronized HeLa S3 cells to radiations and chemical carcinogens during the cell cycle. III. 4-Nitroquinoline 1-oxide and its derivatives.
MedLine Citation:
PMID:  806013     Owner:  NLM     Status:  MEDLINE    
Sensitivity to the chemical carcinogens 4-nitroquinoline 1-oxide (4-NQO) and 4-hydroxyaminoquinoline I-oxide (4-HAQO), during the cell cycle of synchronized HeLa S3 cells, decreases from the late S to the early G2 phases. Cells in other phases are relatively sensitive to both carcinogens. [3-H]4-NQO and [ 3-H]4-HAQO seem to be bound preferably more with cellular DNA of the mitotic phase to the middle of the S phase than with that of the late S phase in which the cells are rather insensitive to these carcinogens. However, we found no significant difference in the excision rates of these carcinogens from the DNA of HeLa S3 cells through the cell cycle. These findings indicate that the cyclic variation of 4-NQO and 4-HAQO cell survivals during the cell cycle may be due to the differences in the amounts of 4-NQO and 4-HAQO bound with cellular DNA.
M Watanabe; M Horikawa
Related Documents :
19233223 - Isolation of azaspiracid-2 from a marine sponge echinoclathria sp. as a potent cytotoxin.
6631473 - Binaural interaction in low-frequency neurons in inferior colliculus of the cat. i. eff...
1453773 - A retinoid acid 'resistant' t(15;17) acute promyelocytic leukemia cell line: isolation,...
Publication Detail:
Type:  In Vitro; Journal Article    
Journal Detail:
Title:  Mutation research     Volume:  28     ISSN:  0027-5107     ISO Abbreviation:  Mutat. Res.     Publication Date:  1975 May 
Date Detail:
Created Date:  1975-09-05     Completed Date:  1975-09-05     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0400763     Medline TA:  Mutat Res     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  295-304     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
4-Hydroxyaminoquinoline-1-oxide / pharmacology*
4-Nitroquinoline-1-oxide / pharmacology*
Aminoquinolines / pharmacology*
Cell Division*
Cell Survival
Cells, Cultured
DNA / metabolism
DNA Repair
Hela Cells / drug effects*
Nitroquinolines / pharmacology*
Time Factors
Reg. No./Substance:
0/Aminoquinolines; 0/Nitroquinolines; 10028-17-8/Tritium; 4637-56-3/4-Hydroxyaminoquinoline-1-oxide; 56-57-5/4-Nitroquinoline-1-oxide; 9007-49-2/DNA

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Reduced DNA repair capacity and increased cytotoxicity following split doses of the mutagen 4-nitroq...
Next Document:  Mutagenicity of organophosphorus compounds in bacteria and Drosophila.